Skip to main content
. 2016 Apr 28;17(12):2268–2279. doi: 10.1093/pm/pnw071

Figure 1.

Figure 1

Diagnostic performance of sex-specific risk prediction models with comparison to other strategies.

Model 1 (purple): sex-specific final reduced risk prediction model (see Tables 2 and 3). Model 2 (blue): model with a four-level daily MED dose only (i.e., <20, 20–49, 50–99, and ≥100 mg). Model 3 (orange): model with a two-level daily MED dose only (i.e., daily MED≥100 mg vs. not).